Pituitary & hypothalamus

Beyond biochemical control: factors associated with quality of life in patients with acromegaly

PituitaryPublished Cross-sectional study

Authors' conclusion

In this predominantly biochemically controlled cohort, disease-specific QoL was more closely associated with depressive symptom burden and educational status than with the clinical variables examined.

Study context

Population
Patients with acromegaly; 46 female, 44 male; 86 in biochemical remission
Participants
90 patients
Outcome
Factors associated with total AcroQoL

Main finding

As reported in the abstract

Factors associated with total AcroQoL (hierarchical multivariable linear regression)

Moderate-to-severe depressive symptoms: largest independent association with lower total AcroQoL, B

- 17.56

95% CI - 25.23 to - 9.89p < 0.001

R² from Model 1 to Model 2

0.206 to 0.365

Observational data: associations, not effects.

Further findings

Median quality of life (QoL) and symptom scores

Median total AcroQoL
76.7
Median Beck Depression Inventory (BDI)
10.5
Median Beck Anxiety Inventory (BAI)
9.0
Median EQ-5D index
0.7
Median EQ-VAS
80.0

Sex and education differences

Female patients had lower total AcroQoL and higher anxiety and depression scores than male patients
Higher educational status associated with better AcroQoL and lower BDI scores

Original publication

Beyond biochemical control: factors associated with quality of life in patients with acromegaly. Pituitary. Published 20 August 2026. doi:10.1007/s11102-026-01746-x

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.